Absci (ABSI) Non-Current Deferred Tax Liability (2021 - 2024)
Absci (ABSI) reported Non-Current Deferred Tax Liability of $175000.0 for Q3 2024, down 29.72% on a YoY basis from $249000.0 in Q4 2023, and little changed sequentially from $175000.0 in Q2 2024.
Absci (ABSI) Non-Current Deferred Tax Liability (2021 - 2024) Analysis & Trends
Absci (ABSI) has 4 years of Non-Current Deferred Tax Liability data on file, last reported at $175000.0 in Q3 2024.
- For the quarter ending Q3 2024, Non-Current Deferred Tax Liability fell 29.72% year-over-year to $175000.0; the trailing twelve-month figure through Sep 2024 stood at $175000.0 (down 29.72% YoY), and the FY2023 full-year result was $186000.0, down 21.85% from the prior year.
- Non-Current Deferred Tax Liability steadied at $175000.0 in Q3 2024, from $175000.0 in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $5.2 million in Q2 2021 to a low of $175000.0 in Q1 2024.
- A 4-year average of $1.0 million and a median of $243500.0 in 2022 frame the typical range for Non-Current Deferred Tax Liability.
- Across the five-year window, Non-Current Deferred Tax Liability tumbled 83.52% in 2023 and fell 21.52% in 2024, its largest moves.
- Tracing ABSI's Non-Current Deferred Tax Liability over 4 years: stood at $743000.0 in 2021, then sank by 67.97% to $238000.0 in 2022, then declined by 21.85% to $186000.0 in 2023, then dropped by 5.91% to $175000.0 in 2024.
- Business Quant data shows ABSI's Non-Current Deferred Tax Liability at $175000.0 in Q3 2024, $175000.0 in Q2 2024, and $175000.0 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 175,000.00 |
| Sep 30, 2024 | 175,000.00 |
| Jun 30, 2024 | 175,000.00 |
| Jun 30, 2024 | 175,000.00 |
| Mar 31, 2024 | 175,000.00 |
| Mar 31, 2024 | 175,000.00 |
| Dec 31, 2023 | 186,000.00 |
| Dec 31, 2023 | 186,000.00 |
| Sep 30, 2023 | 249,000.00 |
| Sep 30, 2023 | 249,000.00 |
| Jun 30, 2023 | 223,000.00 |
| Jun 30, 2023 | 223,000.00 |
| Mar 31, 2023 | 224,000.00 |
| Mar 31, 2023 | 224,000.00 |
| Dec 31, 2022 | 238,000.00 |
| Dec 31, 2022 | 238,000.00 |
| Sep 30, 2022 | 756,000.00 |
| Sep 30, 2022 | 756,000.00 |
| Jun 30, 2022 | 1.09 Mn |
| Jun 30, 2022 | 1.09 Mn |